SciLifeLab Anubis

Submit proposals for grants in open calls.

WASP-DDLS Joint call 2022

53 days remaining.

The research programs DDLS and WASP have a strong ambition to form solid collaborations by bridging the gap between the scientific disciplines of DDLS and WASP respectively. To amplify their collaboration, DDLS and WASP announce a second call for proposals for bridging research projects. The funded projects should span across the thematic profiles of DDLS and WASP, address fundamental research problems between the WASP and DDLS research areas and be of a visionary, high risk – high gain nature.

This call is described in the document Final 2022-12-09 A WASP and DDLS joint call for research projects 2023.docx

The Chemical Biology Consortium Sweden (CBCS) is a national research infrastructure in Sweden funded by the Swedish Research Council, Science for Life Laboratory, and the host universities. We provide world-leading expertise in the field of chemical biology to academic groups across Sweden in a collaborative project model. Our mission is to explore complex biology through the development and application of small molecule tools. To do this we provide support in assay development, small molecule screening, enabling chemistry, as well as access to small-molecule libraries. Additionally, we have recently expanded our services to include disease and compound profiling using Cell Painting, support for functional precision medicine projects, screening of infectious pathogens in biosafety level 2 and 3 laboratories, and automated patch clamp profiling/screening.

We are looking for projects in these areas to support starting August 2023. All applications are ranked by our external project review committee based on scientific potential and feasibility. Prioritized projects receive subsidized support. We require a demonstration of technical feasibility thus we require that you contact CBCS well in advance of the final deadline. See www.cbcs.se for your nearest point of contact.


No cookies are used.
Anubis 2.3.2